Cal-Maine Foods Inc Q3 Profit Falls

Cal-Maine reported Q3 earnings of $50.459M ($1.06 EPS) versus $508.533M ($10.38 EPS) a year ago, an ~90% decline in earnings and EPS. Revenue fell 52.9% to $666.951M from $1.417B, driven by lower egg sales volumes and prices. The company will pay a cash dividend of ~$0.36 per share on May 14 to shareholders of record April 29.

Analysis

This quarter's print looks like a classic cyclical margin shock rather than a structural demand collapse — prices and volumes in shell eggs move on flock cycles, feed costs, and episodic supply shocks (avian influenza). Expect the operating cadence to play out over the next 3–9 months: producers can throttle placements quickly enough to arrest oversupply, but meaningful supply responses to lower margins typically take a full laying-cycle (several months) to show in retail availability and pricing.

Second-order winners will be downstream buyers and processors that use eggs as an input (bakeries, some QSR menu items, and private-label food manufacturers): lower egg costs should flow through to their gross margins within one to two quarters, improving STO margins and retail promotional flexibility. Conversely, regional and vertically integrated egg integrators with higher fixed conversion costs are most at risk of prolonged margin compression and potential consolidation — expect distressed M&A chatter if weak prices persist into late summer.

Tail risks cluster around two binary catalysts: (1) renewed avian influenza outbreaks, which could abruptly tighten supply and send prices sharply higher within weeks, and (2) grain-price shocks (corn/soy) that compress margins irrespective of egg price moves. Near-term market focus will be USDA flock and outbreak reports plus corn/soy trajectories; these will be the quickest triggers to reverse sentiment.

Consensus bearishness likely underprices the optionality from a coordinated flock reduction by large producers, which would produce a meaningful recovery in shell egg pricing in 3–6 months. That said, dividend-dependent holders create asymmetric downside if margin recovery is delayed, so capital structure and liquidity of individual producers matter materially when sizing positions.

Key Decisions for Investors

• Short CALM shares sized to 1–2% of book with 3–9 month horizon — target 20–40% downside if weak pricing persists; hard stop at 15% adverse move. Rationale: cyclically impaired EBITDA and potential dividend stress.
• Buy CALM 3-month put / sell 3-month lower-strike put spread to limit capital and exploit near-term downside while capping carry; size at 0.5–1% of book, target 2:1 reward-to-risk if pricing erosion continues over laying-cycle timeframe.
• Pair trade: short CALM / long WMT (overweight for 3–6 months) — capture relative performance if lower egg costs boost retailer margins and CALM underperforms; hedge ratio 1:1 by notional exposure.
• Hedge tail-risk: buy ADM or Bunge (BG) 6–12 month calls (small allocation) or outright corn call options — protects against an avian-flu-driven supply shock that would make a short CALM position costly.